Emerging evidence suggests that microRNAs (miRNAs) may be pathologically involved in osteoarthritis (OA). Subchondral bone (SCB) sclerosis is accounted for the knee osteoarthritis (KOA) development and progression. In this study, we aimed to screen the miRNA biomarkers of KOA and investigated whether these miRNAs regulate the differentiation potential of mesenchymal stem cells (MSCs) and thus contributing to SCB. We identified 48 miRNAs in the blood samples in KOA patients (n = 5) through microarray expression profiling detection. After validation with larger sample number, we confirmed hsa-miR-582-5p and hsa-miR-424-5p were associated with the pathology of SCB sclerosis. Target genes prediction and pathway analysis were implemented with online databases, indicating these two candidate miRNAs were closely related to the pathways of pluripotency of stem cells and pathology of OA. Surprisingly, mmu-miR-582-5p (homology of hsa-miR-582-5p) was downregulated in osteogenic differentiation and upregulated in adipogenic differentiation of mesenchymal progenitor C3H10T1/2 cells, whereas mmu-mir-322-5p (homology of hsa-miR-424-5p) showed no change through the in vitro study. Supplementing mmumiR-582-5p mimics blocked osteogenic and induced adipogenic differentiation of C3H10T1/2 cells, whereas silencing of the endogenous mmu-miR-582-5p enhanced
| INTRODUCTION
Knee osteoarthritis (KOA) is the most common degenerative joint disease and affects >1.12 billion residents in China (Tang et al., 2016) .
Clinically, the KOA victims present as radiographic narrowing of joint space accompanied with articular cartilage destruction, subchondral bone (SCB) sclerosis and osteophyte formation at joint margin, resulting in chronic joint pain and physical disability (Lawrence,et al., 2008) . Current treatment strategies could not effectively delay or attenuate the progression of the disease. Although great efforts were taken into the research of KOA, no one can explain the exact pathogenesis of the disease.
Understanding the underlying pathogenesis and mechanisms could facilitate the development of novel therapies. Articular cartilage degradation is the primary concern in KOA (Zhen et al., 2013) as it usually appears earlier (Juneja, Ventura, Jay, & Veillette, 2016) , but the importance of other joint tissues especially SCB cannot be ignored. A growing number of investigators preferred to define KOA as a disease of the whole joint, the integrity and hemostasis of articular cartilage rely on the biochemical and biomechanical interplay with SCB and other joint tissues (Lories & Luyten, 2011) . At the early stage of KOA, the articular cartilage and SCB interface underwent remodeling, especial beneath the regions of articular cartilage damage which eventually cause SCB sclerosis and finally precede cartilage degeneration in return. Several reports suggest that SCB changes involved in the onset of KOA. SCB provides mechanical support for the overlying articular cartilage and bears most of the mechanical force. Furthermore, it also counts for the metabolism of articular cartilage (Madry, van Dijk, & Mueller-Gerbl, 2010) . A recent study showed that inhibition of SCB sclerosis could attenuate osteoarthritis (OA) progression (Zhen et al., 2013) .
Apparently, effective prevention of SCB sclerosis might be a key objective of new therapeutic approaches.
In consideration of the effectiveness of current treatment, the major challenge faced by KOA research is early diagnosis and identify patients with fast progression of KOA disease (Glyn-Jones, Palmer, & Agricola, 2015) . Clinically, KOA is diagnosed radiographically when clinical signs of pain and stiffness have already appeared. Moreover, many patients were diagnosed in the middle and late stages.
Therapeutic intervention in OA has been limited by insufficient approaches of early diagnosis (Kung et al., 2017) . Above all, it is urgently needed to developing sensitive and specific biomarkers not only for early diagnosis but also for the novel strategy for clinical treatment.
MicroRNAs (miRNAs) are short noncoding 18-24 nucleotides
RNAs that regulate target genes expression by influencing messenger RNA (mRNA) degradation and/or inhibiting RNA expression, and they have been found in different organisms. Previous data showed that about 30% mammalian mRNAs seem to be regulated by miRNAs (Lewis, Burge, & Bartel, 2005) . Recently, increasing evidence indicated miRNAs as promising diagnostic biomarkers for many diseases including gastric cancer (Kao et al., 2017) , renal cell carcinoma (Petrozza et al., 2017) and atherogenesis (Vilahur, 2017) .
Furthermore, miRNAs also acted as potential targets for therapeutic.
In KOA, miRNAs cannot only predict early cartilage degeneration (Kung et al., 2017) , but also have the function of proinflammation and catabolism/anabolism in the pathophysiology of the disease (Alcaraz, Megías, García-Arnandis, Clérigues, & Guillén, 2010) . It has been reported that regulation of miRNAs expression could prevent matrix degradation and cartilage degeneration (Chen & Tian, 2017; Yu & Wang, 2018) . Although several studies are exploring the role of miRNA in KOA, they tend to focus on cartilage degradation, but not the role of miRNAs in SCB.
As SCB plays an important role in KOA development, we hypothesized that circulating miRNAs may have a significant role in KOA subchondral bone sclerosis. To confirm this hypothesis, we have performed following studies: (a) measuring the expression differences of circulating miRNA between KOA patients and non-KOA subjects; (b) validating the data using larger sample size; (c) validating the candidate miRNAs using an independent set of SCB specimens; (d) analyzing data using Gene Ontology (GO) analysis and Kyoto Encyclopedia Genes and Genomes (KEGG) pathway analysis to identify the target genes and signaling pathways; (e) investigating the exact role of candidate miRNA by transfection in mesenchymal stem cells (MSCs).
| MATERIALS AND METHODS

| Patients and human samples
Whole blood samples were collected from the KOA patients (diagnosed according to the criteria listed in Figure 1b , n = 31) and age-matched non-KOA volunteers (n = 22) at the first affiliated hospital of Zhejiang Chinese Medical University. At least 3 ml peripheral blood was mixed with 9 ml red blood cells lysis buffer, the supernatant was removed after a brief centrifugation and stored at −80°C until further use. We screened five KOA and five non-KOA blood samples, respectively, for further miRNA microarray expression profiling to detect differentially expressed circulating miRNAs (Figure 1a) . SCB was obtained from the KOA individuals intraoperatively, severe KOA sclerotic bone (showed complete cartilage degeneration with exposed bone, n = 6) and nonsclerotic KOA bone (showed full cartilage thickness on top of it, n = 4) were separated from the specimens as previously reported (Prasadam et al., 2016) , immediately scanned for micro-CT analysis and stored at −80°C for miRNAs detection.
All methods were performed in accordance with the relevant guidelines and regulations of Zhejiang Chinese Medical University and were approved by its ethical committee.
| RNA and miRNA extraction
Total RNA was extracted from blood and SCB using mirVana™ RNA Isolation Kit (Thermo Fisher Scientific, MA, p/n AM1556) according to the manufacturer's instructions. The yield of RNA was measured by NanoDrop spectrophotometer (Thermo Fisher Scientific), and the integrity was evaluated using agarose gel electrophoresis stained with ethidium bromide. Table 1 . The expression levels of miRNAs were normalized to U6 respectively as endogenous control and were calculated using the −ΔΔ 2 Ct method (Livak & Schmittgen, 2001) .
| miRNA expression profiling
F I G U R E 1 (a) A flowchart illustrates how we identified circulating miRNAs. We performed a systematic miRNA analysis on blood samples from KOA patients (n = 5) and healthy controls (n = 5), 48 circulating miRNAs have significant (p < 0.05) changes in expression. Six candidate miRNAs have been selected after we verified the different miRNAs according to their repeatability and homogeneity in each sample. Two different expressed miRNAs were confirmed with blood from 26 OA patients and 17 health control using real-time polymerase chain reaction assay. These two miRNAs were measured in severe KOA sclerotic SCB (n = 6) and nonsclerotic SCB (n = 4) to confirm the expression difference. SH30243.01) which contained 10% fetal bovine serum (FBS) plus 50 U/ml penicillin and 50 mg/ml streptomycin. The expendcultured cells then were cultured in the osteoblast-induced medium (OIM, DMEM supplemented with 10% FBS, 50 μg/ml of ascorbic acid and 10 mM β-glycerophosphate) to induce osteogenic differentiation. To induce adipogenic differentiation, cells were induced in the adipocyte-inducing medium (AIM, DMEM supplemented with 10% FBS, 1 M dexamethasone, 0.5 mM methylisobutylxanthine, 10 g/ml of insulin, and 100 M indomethacin) for 3 days and then cultured in the following adipocyte-maintaining medium (AMM, DMEM supplemented with 10% FBS and 10 μg/ml of insulin) for 2 days.
| Validation of candidate miRNAs in differentiated cells
Previously selected candidate miRNAs were testified in two differentiated cells: Osteogenic differentiation cells and adipogenic differentiation cells. mmu-miR-582-5p and mmu-miR-322-5p were highly homologous with hsa-miR-582-5p and hsa-miR-424-5p as showed in MiRbase (www.mirbase.org), respectively. After differentiation, two differentially expressed miRNAs were validated in these cells by qRT-PCR.
| Transfection
The synthetic mimics or inhibitors of mmu-miR-582-5p ( 
| Luciferase reporter assay
Target mRNAs were predicted as described above. Note. hsa-miR-424-5p and hsa-miR-582-5p are highly homologous to mmu-miR-322-5p and mmu-miR-582-5p, respectively, as showed in miRbase (www.mirbase.org). ALP: alkaline phosphatase; PPARγ: peroxisome proliferator-activated receptor γ.
TG ACATAATTGAATTATTTGGCATTTCC-3′, mut-Runx2 antisense: 5′-T CGAGGAAATGCCAAAT AATTCAATTATGTCAACGTTGATACAATACA AATAGTCCCTTTGAAGTTCAGAGCT-3′. The PCR products were cloned into pMir-report vector (for LRP6 and RICTOR) at SacI/HindIII sites, or into pmirGLO vector (for Runx2) at SacI/XhoI sites using the ClonExpress II One
Step Cloning Kit (Vazyme, Nanjing, China). miR-mimics or its negative control was cotransfected into HEK-293 cells along with the 3′ UTR constructs in a 24-well plates. The Renilla luciferase reporter plasmid pRL-SV40 was also included for the cotransfection to monitor the transfection efficiency (for pMir-report vector). The cells were harvested 36 hr after transfection and luciferase activity was measured using a dual-luciferase reporter assay kit (Promega, San Luis Obispo, CA).
The relative firefly luciferase activity was determined as the ratio of firefly to Renilla luciferase activity.
| Alkaline phosphatase (ALP)/oil red O staining
After 16 hr transfection, the cells were cultured in 24-well plates for osteogenic/adipogenic induction. 
| Statistical analysis
In the present work, the statistical package for the social sciences (version 24.0; SPSS Inc, Chicago, IL) was used to perform statistical analysis. The results were presented as mean and standard deviation.
An independent the Student t test was used to examine statistical comparison. p < 0.05 considered as statistically significant variation between groups.
3 | RESULTS 3.1 | hsa-miR-582-5p and hsa-miR-424-5p were downregulated in KOA blood compared with non-KOA First, we performed global miRNA profiling in blood from five KOA patients and five healthy controls to figure out the difference between two groups. Briefly, we used Agilent Human miRNA chips that contain 60,000 probes for 1,888 human microRNAs (miRbase 19.0). After probe screening and data normalization, we found 48 significantly and differentially expressed miRNAs between two groups, which contains 39 upregulated miRNAs and 9 downregulated miRNAs (Figure 2a,b) . We next verified the expression tendency for candidate miRNAs in these 10 samples by qRT-PCR. Surprisingly, 42 candidate miRNAs were not showed the same expression tendency in the samples of the same group, whereas six candidate miRNAs include two upregulated miRNAs and four downregulated miRNAs were confirmed to the next validation stage as follow: hsa-miR-424-5p, hsa-miR-371a-5p, hsa-miR-197-3p, hsamiR-125a-3p, hsa-miR-582-5p, and hsa-miR-338-3p. We then enlarged the blood samples of KOA patients (n = 26) and non-KOA controls (n = 17) to further confirm the six candidate miRNAs expression in two groups. As a result, hsa-miR-582-5p
and hsa-miR-424-5p were significantly decreased in KOA patients, conversely, another four miRNAs showed no difference between two groups (Figure 2c ).
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3.2 | hsa-miR-582-5p and hsa-miR-424-5p were significantly decreased in KOA sclerotic bone compared with nonsclerotic bone
It is well accepted that all parts of the joint, especially articular cartilage and SCB, contribute to KOA pathology. Clinically, patients with KOA often show cartilage degradation associated with SCB sclerosis. In this study, we identified the characteristics of sclerotic and nonsclerotic SCB in KOA. X-ray detection showed an obvious joint clearance narrowing and SCB sclerosis in the medial compartment ( Figure 3a) . A representative sample from total knee arthroplasty of KOA patient showed the sclerotic and nonsclerotic areas of knee tibia plate (Figure 3b ). These two areas were subsequently dissected into small squares for morphological analysis.
3D reconstruction analysis of μCT scanning showed that the microstructure of sclerotic SCB was thicker and denser than the nonsclerotic SCB (Figure 3c ). Alcian Blue Hematoxylin/Orange G (ABH/OG) staining of the sclerotic histological section also pointed out its changes with a thicker SCB and thinner damaged cartilage appearance than nonsclerotic section (Figure 3d ). Morphometric analysis of μCT data indicated that the bone volume/total volume (BV/TV), bone mineral density (BMD) and trabecular bone thickness (Tb. Th) of sclerotic bone trabeculae were higher than nonsclerotic bone and the trabecular bone separation (Tb. Sp) and trabecular bone pattem factor (Tb. Pf) were conversely lower (Figure 3e-i) . These findings revealed that bone remodeling in the sclerotic area was more active than non-sclerotic area, which probably due to the excessive osteogenic differentiation of stem cells.
Recent studies suggest that miRNAs can impede SCB sclerosis by downregulation of osteogenic differentiation. According to this, we conducted a second validation to determine if these differentially expressed miRNAs were involved in the pathology of SCB sclerosis.
We then collected six sclerotic bones and four nonsclerotic bones from six KOA patients and detected the expression levels of the two candidate miRNAs. As we speculated, hsa-miR-582-5p and hsa-miR-424-5p were significantly downregulated in SCB sclerotic area compared with the nonsclerotic area (Figure 3j ).
| Potential gene targets and pathways regulated by identified miRNAs
To identify the target genes of those differentially expressed miRNAs, we used three databases as follows: Targetscan, microRNA, and PITA.
Finally, 225 target genes that appeared in all three databases ( Figure   4a ) were selected as the target genes of the candidate miRNAs. To determine the biological relevance of these potential target genes, we conducted an enrichment pathway analysis with GO and KEGG.
Analysis with GO biological process indicated that these highly correlated target genes were involved in BMP (Bone Morphogenetic Protein) and transforming growth factor β (TGF β) receptor signaling pathway. KEGG pathway analysis indicated that these target genes were participated in signaling pathways regulating pluripotency of stem cells, TGF β, hippo, and AMPK (Adenosine 5'-Monophosphate-activated Protein Kinase) signaling pathway (Figure 4b ,c), these signaling pathways are all involved in OA pathogenesis (Wang et al., 2017a; Wu et al., 2012; Ying et al., 2018) .
| miR-582-5p downregulates osteogenic differentiation while upregulates adipogenic differentiation of MSCs
First, C3H10T1/2 mesenchymal progenitor cells were induced to osteoblast and adipocyte. We found that two differential expressed F I G U R E 3 Expression of hsa-miR-582-5p and hsa-miR-424-5p in the subchondral bone of knee osteoarthritis (KOA) patients was confirmed to be lower in sclerosis area than nonsclerosis area. (a-c) X-ray, gross appearance and micro-computed tomography (μCT) 3D image were used to distinguish the sclerotic area and nonsclerotic area to facilitate the next subchondral bone (SCB) validation. (d) Alcian Blue Hematoxylin/ Orange G staining showed the structure of cartilage and subchondral bone in KOA sclerotic area and nonsclerotic area. (e-i) The quantification of SCB trabecular bone parameters measured by μCT. (j) As blood sample validation, hsa-miR582-5p and hsa-miR424-5p have the same expression tendency between sclerotic bone and nonsclerotic bone. All data are shown as mean ± SD. *p < 0.05, **p < 0.01. 
| Runx2 was directly targeted by miR-582-5p
The predicted potential targets of miR-582-5p in osteogenic and adipogenic differentiation include LRP6, RICTOR, Runx2 based on the online databases described above. To identify the direct targets of miR-582-5p, the reporter constructs of their 3′UTR were established and luciferase reporter assay was performed (Figure 6a ). Only the luciferase activity of Runx2 3′UTR reporter was inhibited by miR-582-5p mimics (Figure 6b,d ). To further determine if miR-582-5p directly binds to 3′UTR of Runx2, we constructed the mut-Runx2 3′UTR reporter transfected with
F I G U R E 4 Blue pie represents TargetScan database which predicts 6,003 genes, microRNAorg database (orange pie) predicts 7,760 genes, meanwhile green pie (PITA database) predicts 431 genes, 225 genes showed in three predict databases were chosen as target genes for the next enrichment pathway analysis (a), GO biological process predicts two pathways (b) and KEGG predicts four pathways that highly related to OA which highlighted by red color (c) 
| DISCUSSION
KOA is a whole joint disease affecting not only cartilage, bone, and synovium, but also bone marrow, muscle, menisci, ligament and neural tissue (Brandt, Radin, Dieppe, & van de Putte, 2006) . To date, it's difficult to determine that KOA is initiated from which part of joint tissue. Articular cartilage is an avascular tissue, while the underlying bone plate is highly vascularized and provide more than 50% of the hyaline cartilage nutrition (Imhof et al., 2000) .
Many studies suggested that SCB remodeling was taken place in the onset of KOA (Maerz et al., 2016; Poulet et al., 2015; Zhao et al., 2016) . At the early stage of KOA, bone marrow lesion (BML) appears as increased remodeling of SCB and marrow in the response of mechanical overload, it is closely related to cartilage loss and development of KOA (Hunter et al., 2006; Roemer et al., 2009) . With the development of the disease, uncoupled SCB remodeling leads to bone sclerosis which may interfere with the articular cartilage hemostasis. Previous studies showed that inhibition of SCB sclerosis could prevent cartilage degeneration (Lin et al., 2018; Zhen et al., 2013) . A series of molecules were involved in the complicated process of SCB sclerosis, the underlying mechanisms have not been (Chen et al., 2015; Hellingman et al., 2011; Wang et al., 2017a; Zhen et al., 2013) . Hippo signaling pathway activation could downregulate the expression of Runx2 and Col10 to prevent chondrocyte hypertrophy. Moreover, the majority of these signaling pathways are involved in the regulation of pluripotency and differentiation of stem cells (Cao, Lv, & Lv, 2015; Cheung et al., 2014; Wang, Cai, Cai, & Chen, 2013) , which may break the balance between osteogenesis and adipogenesis of MSCs subsequently leading to SCB sclerosis and OA development.
MSCs could be easily collected and exhibit the strong ability of self-renew and multi-directional differentiation potential (Trounson & McDonald, 2015) , such as differentiation into chondrocytes, osteoblasts and other types of cells under different microenvironment. Studies showed that MSCs were recruited to SCB and differentiated into osteoblasts for bone formation during or after anterior cruciate ligament transection (ACLT; Zhen et al., 2013) . In clinics, MSC cells derived from OA patients showed high osteogenic differentiation capacity and low adipogenic differentiation tendency (Lian et al., 2017; Salamon et al., 2013; Xia et al., 2016) (You, Pan, Chen, Gu, & Chen, 2016) . MiR-31-5p and miR-424-5p were decreased in OA cartilage derived MSCs, as these cells show lower adipogenic and higher osteogenic capacity (Xia et al., 2016) . In our study, miR-582-5p was reduced during miR-582-5p has already been studied in several previous studies. Its' overexpression could targeting FOXC1 to repressing the activity of salivary adenoid cystic carcinoma cell (Wang et al., 2017b) , facilities colorectal cancer cell and prostate cancer cell proliferation (Shu, Chen, & Ding, 2016; Zhanget al., 2015) . Moreover, it can also impede apoptosis of monocytes involving in the progression of tuberculosis (Liu, Jiang, Wang, Zhai, & Cheng, 2013) .
To date, the role of miR-582-5p in the regulation of stem cell pluripotency and KOA development has not been reported. We discovered that miR-582-5p was significantly downregulated in 
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